West Nyack, NY, United States of America

Gurmukh Chanana

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wyeth. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gurmukh Chanana. Retrieved from https://idiyas.com/inventor/gurmukh-chanana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gurmukh Chanana: Innovator in Pharmaceutical Manufacturing

Introduction

Gurmukh Chanana is a notable inventor based in West Nyack, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the manufacturing processes of important medications. His work has had a meaningful impact on the medical community.

Latest Patents

Gurmukh Chanana holds a patent for a manufacturing process for tigecycline. This patent discloses a method for the preparation of tigecycline that is suitable for intravenous infusion. His innovative approach enhances the efficiency and effectiveness of this important antibiotic.

Career Highlights

Chanana is associated with Wyeth, a prominent pharmaceutical company known for its commitment to research and development. His role at Wyeth has allowed him to contribute to the advancement of medical treatments through his inventive processes.

Collaborations

Some of Gurmukh Chanana's coworkers include Dominic Ventura and Richard William Saunders. Their collaboration in the pharmaceutical field has fostered an environment of innovation and progress.

Conclusion

Gurmukh Chanana's contributions to pharmaceutical manufacturing, particularly through his patent for tigecycline, highlight his role as an important inventor in the industry. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…